Literature DB >> 19713709

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide.

Dik J Kwekkeboom1, Eric P Krenning, Klemens Scheidhauer, Val Lewington, Rachida Lebtahi, Ashley Grossman, Pavel Vitek, Anders Sundin, Ursula Plöckinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19713709     DOI： 10.1159/000225946

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN： 0028-3835            Impact factor:   4.914


× No keyword cloud information.
  48 in total

1.  18F-FDOPA PET/CT imaging of insulinoma revisited.

Authors:  Alessio Imperiale; Frédéric Sebag; Michel Vix; Frédéric Castinetti; Laurence Kessler; François Moreau; Philippe Bachellier; Benjamin Guillet; Izzie-Jacques Namer; Olivier Mundler; David Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-01       Impact factor: 9.236

2.  Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE.

Authors:  Irene Virgolini; Valentina Ambrosini; Jamshed B Bomanji; Richard P Baum; Stefano Fanti; Michael Gabriel; Nikolaos D Papathanasiou; Giovanna Pepe; Wim Oyen; Clemens De Cristoforo; Arturo Chiti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-10       Impact factor: 9.236

3.  Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors.

Authors:  Jessica E Maxwell; Scott K Sherman; Yusuf Menda; Donghong Wang; Thomas M O'Dorisio; James R Howe
Journal:  J Surg Res       Date:  2014-05-21       Impact factor: 2.192

4.  Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours.

Authors:  S Van Binnebeek; B Vanbilloen; K Baete; C Terwinghe; M Koole; F M Mottaghy; P M Clement; L Mortelmans; K Bogaerts; K Haustermans; K Nackaerts; E Van Cutsem; C Verslype; A Verbruggen; C M Deroose
Journal:  Eur Radiol       Date:  2015-07-12       Impact factor: 5.315

Review 5.  Neuroendocrine tumours: the role of imaging for diagnosis and therapy.

Authors:  Martijn van Essen; Anders Sundin; Eric P Krenning; Dik J Kwekkeboom
Journal:  Nat Rev Endocrinol       Date:  2013-12-10       Impact factor: 43.330

6.  Repeatability of gallium-68 DOTATOC positron emission tomographic imaging in neuroendocrine tumors.

Authors:  Yusuf Menda; Laura L Boles Ponto; Michael K Schultz; Gideon K D Zamba; G Leonard Watkins; David L Bushnell; Mark T Madsen; John J Sunderland; Michael M Graham; Thomas M O'Dorisio; M Sue O'Dorisio
Journal:  Pancreas       Date:  2013-08       Impact factor: 3.327

Review 7.  Biochemical Diagnosis and Preoperative Imaging of Gastroenteropancreatic Neuroendocrine Tumors.

Authors:  Jessica E Maxwell; Thomas M O'Dorisio; James R Howe
Journal:  Surg Oncol Clin N Am       Date:  2015-10-31       Impact factor: 3.495

8.  Preoperative localization of an insulinoma: selective arterial calcium stimulation test performance.

Authors:  J Morera; A Guillaume; P Courtheoux; L Palazzo; A Rod; M Joubert; Y Reznik
Journal:  J Endocrinol Invest       Date:  2015-11-17       Impact factor: 4.256

9.  Clinical Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Diagnostic Algorithm of Advanced Entero-Pancreatic Neuroendocrine Neoplasms.

Authors:  Maria Rinzivillo; Stefano Partelli; Daniela Prosperi; Gabriele Capurso; Patrizia Pizzichini; Elsa Iannicelli; Elettra Merola; Francesca Muffatti; Francesco Scopinaro; Orazio Schillaci; Matteo Salgarello; Massimo Falconi; Gianfranco Delle Fave; Francesco Panzuto
Journal:  Oncologist       Date:  2017-11-08

10.  Imaging in neuroendocrine tumors: an update for the clinician.

Authors:  Jessica E Maxwell; James R Howe
Journal:  Int J Endocr Oncol       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.